Critical appraisal of rotigotine transdermal system in management of Parkinson's disease and restless legs syndrome - patient considerations
{{output}}
Rotigotine (RTG) is a dopamine agonist that is used as mono and adjunct therapy to treat Parkinson's disease, and as therapy for moderate-to-severe restless legs syndrome. RTG is the only dopamine agonist currently available as a 24-hour/day transdermal system... ...
